Therefore, we realized that to overcome the MDR and metastasis of breast cancer, a highly efficient nanocomposite that is capable of not only synergistically enhancing DOX-induced chemotherapy and ICD but also of downregulating the intracellular expression of P-gp, needs to be developed. The gene discussed is PGP; the disease is breast carcinoma.